help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, M. R.
Right arrow Articles by Vale, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, M. R.
Right arrow Articles by Vale, W.

Endocrinology, Vol 111, 928-931, Copyright © 1982 by Endocrine Society

ARTICLES

Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism

MR Brown, LA Fisher, J Spiess, C Rivier, J Rivier and W Vale

Corticotropin-releasing factor (CRF) injected into the brains of rats produces hyperglycemia and an increase in plasma concentrations of glucagon, epinephrine, and norepinephrine. Neither hypophysectomy nor adrenalectomy prevents CRF-induced hyperglycemia. However, a role of adrenal epinephrine release in mediating CRF-induced hyperglycemia is supported by the finding that the central nervous system-selective somatostatin analog, desAA1,2,4,5,12,13-[D-Trp8]somatostatin, totally prevents the elevation of plasma epinephrine and suppresses the rise of plasma glucose but does not alter the increase in plasma norepinephrine induced by CRF. Pretreatment with the ganglionic blocker chlorisondamine completely prevents the CRF-induced rises in plasma glucose, epinephrine, and norepinephrine. These results demonstrate that CRF acts within the brain to stimulate sympathetic outflow, which results in the development of hyperglycemia. In contrast to other peptides that act within the central nervous system, e.g. bombesin, TRF, and beta-endorphin, whose hyperglycemic actions depend exclusively on adrenal epinephrine secretion, CRF-induced hyperglycemia is secondary to the enhanced secretion of both epinephrine and norepinephrine.


This article has been cited by other articles:


Home page
 J EndocrinolHome page
C. Doyon, P. Samson, J. Lalonde, and D. Richard
Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats
J. Endocrinol., April 1, 2007; 193(1): 11 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Chen, B. Brar, C. S. Choi, D. Rousso, J. Vaughan, Y. Kuperman, S. N. Kim, C. Donaldson, S. M. Smith, P. Jamieson, et al.
Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle
PNAS, October 31, 2006; 103(44): 16580 - 16585.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. C. Rogers, G. E. Hermann, and R. A. Travagli
Stress and the colon: central-vagal or direct peripheral effect of CRF?
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1535 - R1536.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. M. Carlin, W. W. Vale, and T. L. Bale
Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis
PNAS, February 28, 2006; 103(9): 3462 - 3467.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
P. Harle, T. Bongartz, J. Scholmerich, U. Muller-Ladner, and R. H. Straub
Predictive and potentially predictive factors in early arthritis: a multidisciplinary approach
Rheumatology, April 1, 2005; 44(4): 426 - 433.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
O. Chan, K. Inouye, E. Akirav, E. Park, M. C. Riddell, M. Vranic, and S. G. Matthews
Insulin Alone Increases Hypothalamo-Pituitary-Adrenal Activity, and Diabetes Lowers Peak Stress Responses
Endocrinology, March 1, 2005; 146(3): 1382 - 1390.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Chen, M. Perrin, B. Brar, C. Li, P. Jamieson, M. DiGruccio, K. Lewis, and W. Vale
Mouse Corticotropin-Releasing Factor Receptor Type 2{alpha} Gene: Isolation, Distribution, Pharmacological Characterization and Regulation by Stress and Glucocorticoids
Mol. Endocrinol., February 1, 2005; 19(2): 441 - 458.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. Daniels, S. Markison, H. J. Grill, and J. M. Kaplan
Central Structures Necessary and Sufficient for Ingestive and Glycemic Responses to Urocortin I Administration
J. Neurosci., December 15, 2004; 24(50): 11457 - 11462.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
Y. Oomura, S. Aou, I. Matsumoto, and T. Sakata
Physiological Significance of 2-Buten-4-Olide (2-B4O), an Endogenous Satiety Substance Increased in the Fasted State
Experimental Biology and Medicine, November 1, 2003; 228(10): 1146 - 1155.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. L. Bale, K. R. Anderson, A. J. Roberts, K.-F. Lee, T. R. Nagy, and W. W. Vale
Corticotropin-Releasing Factor Receptor-2-Deficient Mice Display Abnormal Homeostatic Responses to Challenges of Increased Dietary Fat and Cold
Endocrinology, June 1, 2003; 144(6): 2580 - 2587.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. S. Mondal, Y. Date, N. Murakami, K. Toshinai, T. Shimbara, K. Kangawa, and M. Nakazato
Neuromedin U acts in the central nervous system to inhibit gastric acid secretion via CRH system
Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G963 - G969.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. E. Flanagan, T. Keshavarz, M. L. Evans, S. Flanagan, X. Fan, R. J. Jacob, and R. S. Sherwin
Role of Corticotrophin-Releasing Hormone in the Impairment of Counterregulatory Responses to Hypoglycemia
Diabetes, March 1, 2003; 52(3): 605 - 613.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Gomez, H. Houshyar, and M. F. Dallman
Marked Regulatory Shifts in Gonadal, Adrenal, and Metabolic System Responses to Repeated Restraint Stress Occur within a 3-Week Period in Pubertal Male Rats
Endocrinology, August 1, 2002; 143(8): 2852 - 2862.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F.-C. Chang and M. R. Opp
Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R400 - R407.
[Abstract] [Full Text] [PDF]

Home page
 Integr. Comp. Biol.Home page
J. A. Carr
Stress, Neuropeptides, and Feeding Behavior: A Comparative Perspective
Integr. Comp. Biol., July 1, 2002; 42(3): 582 - 590.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
G. PONGRATZ, B. ZIETZ, T. GLUCK, J. SCHOLMERICH, and R. H. STRAUB
Corticotropin-Releasing Factor Modulates Cardiovascular and Pupillary Autonomic Reflexes in Man: Is there a Link to Inflammation-Induced Autonomic Nervous Hyperreflexia?
Ann. N.Y. Acad. Sci., June 1, 2002; 966(1): 373 - 383.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. L. Bale, F. J. Giordano, R. P. Hickey, Y. Huang, A. K. Nath, K. L. Peterson, W. W. Vale, and K.-F. Lee
Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization
PNAS, May 28, 2002; 99(11): 7734 - 7739.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
G. Grassi, G. Seravalle, R. Dell'Oro, C. Turri, L. Pasqualinotto, M. Colombo, and G. Mancia
Participation of the Hypothalamus-Hypophysis Axis in the Sympathetic Activation of Human Obesity
Hypertension, December 1, 2001; 38(6): 1316 - 1320.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Remage-Healey and L. M. Romero
Corticosterone and insulin interact to regulate glucose and triglyceride levels during stress in a bird
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R994 - R1003.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. J. Cullen, N. Ling, A. C. Foster, and M. A. Pelleymounter
Urocortin, Corticotropin Releasing Factor-2 Receptors and Energy Balance
Endocrinology, March 1, 2001; 142(3): 992 - 999.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. J. Bradbury, M. I. McBurnie, D. A. Denton, K.-F. Lee, and W. W. Vale
Modulation of Urocortin-Induced Hypophagia and Weight Loss by Corticotropin-Releasing Factor Receptor 1 Deficiency in Mice
Endocrinology, August 1, 2000; 141(8): 2715 - 2724.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. J. MacNeil, A. H. Jansen, A. H. Greenberg, and D. M. Nance
Effect of acute adrenalectomy on sympathetic responses to peripheral lipopolysaccharide or central PGE2
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2000; 278(5): R1321 - R1328.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. M. Sapolsky, L. M. Romero, and A. U. Munck
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions
Endocr. Rev., February 1, 2000; 21(1): 55 - 89.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M.-L. Wong, M. A. Kling, P. J. Munson, S. Listwak, J. Licinio, P. Prolo, B. Karp, I. E. McCutcheon, T. D. Geracioti Jr., M. D. DeBellis, et al.
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone
PNAS, January 4, 2000; 97(1): 325 - 330.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Chen and S. Reichlin
Mechanisms by Which Blood Levels of Interleukin-6 (IL-6) Are Elevated after Intracerebroventricular Injection of IL-1{beta} in the Rat: Neural Versus Humoral Control
Endocrinology, December 1, 1999; 140(12): 5549 - 5555.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
M. C. Lekas, S. J. Fisher, B. El-Bahrani, M. van Delangeryt, M. Vranic, and Z. Q. Shi
Glucose uptake during centrally induced stress is insulin independent and enhanced by adrenergic blockade
J Appl Physiol, August 1, 1999; 87(2): 722 - 731.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Casadevall, E. Saperas, J. Panes, A. Salas, D. C. Anderson, J. R. Malagelada, and J. M. Pique
Mechanisms underlying the anti-inflammatory actions of central corticotropin-releasing factor
Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G1016 - G1026.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. B. HENNESSY, H. N. DAVIS, A. E. McCREA, A. T. HARVEY, and M. T. WILLIAMS
Short- and Long-term Consequences of Corticotropin-releasing Factor in Early Development
Ann. N.Y. Acad. Sci., January 1, 1999; 897(1): 76 - 91.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
O. Yamamoto, H. Niida, K. Tajima, Y. Shirouchi, Y. Kyotani, F. Ueda, M. Kise, and K. Kimura
Effect of YNS-15P, a New Alpha-2 Adrenoceptor Antagonist, on Stress-Stimulated Colonic Propulsion in Rats
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 691 - 696.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
I. Matsumoto, A. Niijima, Y. Oomura, K. Sasaki, K. Tsuchiya, and T. Aikawa
Acidic fibroblast growth factor activates adrenomedullary secretion and sympathetic outflow in rats
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1003 - R1012.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Ogilvie and C. Rivier
The Intracerebroventricular Injection of Interleukin-1{beta} Blunts the Testosterone Response to Human Chorionic Gonadotropin: Role of Prostaglandin- and Adrenergic-Dependent Pathways
Endocrinology, July 1, 1998; 139(7): 3088 - 3095.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
I. Dijkstra, F. J. H. Tilders, G. Aguilera, A. Kiss, C. Rabadan-Diehl, N. Barden, S. Karanth, F. Holsboer, and J. M. H. M. Reul
Reduced Activity of Hypothalamic Corticotropin-Releasing Hormone Neurons in Transgenic Mice with Impaired Glucocorticoid Receptor Function
J. Neurosci., May 15, 1998; 18(10): 3909 - 3918.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. A. DEMITRACK and L. J. CROFFORD
Evidence for and Pathophysiologic Implications of Hypothalamic-Pituitary-Adrenal Axis Dysregulation in Fibromyalgia and Chronic Fatigue Syndrome
Ann. N.Y. Acad. Sci., May 1, 1998; 840(1): 684 - 697.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Ghizzoni, G. Mastorakos, A. Vottero, A. Barreca, M. Furlini, A. Cesarone, B. Ferrari, G. P. Chrousos, and S. Bernasconi
Corticotropin-Releasing Hormone (CRH) Inhibits Steroid Biosynthesis by Cultured Human Granulosa-Lutein Cells in a CRH and Interleukin-1 Receptor-Mediated Fashion
Endocrinology, November 1, 1997; 138(11): 4806 - 4811.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. C. E. Linthorst, C. Flachskamm, S. J. Hopkins, M. E. Hoadley, MartaS. Labeur, F. Holsboer, and J. M. H. M. Reul
Long-Term Intracerebroventricular Infusion of Corticotropin-Releasing Hormone Alters Neuroendocrine, Neurochemical, Autonomic, Behavioral, and Cytokine Responses to a Systemic Inflammatory Challenge
J. Neurosci., June 1, 1997; 17(11): 4448 - 4460.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. C. Heinrichs, J. Lapsansky, D. P. Behan, R. K. W. Chan, P. E. Sawchenko, M. Lorang, N. Ling, W. W. Vale, and E. B. De Souza
Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal
PNAS, December 24, 1996; 93(26): 15475 - 15480.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
G. S. TANNENBAUM
Response: Effects of Growth Hormone-Releasing Factor in the Brain
Science, June 6, 1986; 232(4755): 1272 - 1273.
[PDF]

Home page
 ScienceHome page
C. Nemeroff, E Widerlov, G Bissette, H Walleus, I Karlsson, K Eklund, C. Kilts, P. Loosen, and W Vale
Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
Science, December 14, 1984; 226(4680): 1342 - 1344.
[Abstract] [PDF]

Home page
 ScienceHome page
E. De Souza, M. Perrin, T. Insel, J Rivier, W. Vale, and M. Kuhar
Corticotropin-releasing factor receptors in rat forebrain: autoradiographic identification
Science, June 29, 1984; 224(4656): 1449 - 1451.
[Abstract] [PDF]

Home page
 ScienceHome page
J Rivier, C Rivier, and W Vale
Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat
Science, May 25, 1984; 224(4651): 889 - 891.
[Abstract] [PDF]

Home page
 ScienceHome page
D. Krieger
Brain peptides: what, where, and why?
Science, December 2, 1983; 222(4627): 975 - 985.
[Abstract] [PDF]

Home page
 ScienceHome page
Y Tache, Y Goto, M. Gunion, W Vale, J River, and M Brown
Inhibition of gastric acid secretion in rats by intracerebral injection of corticotropin-releasing factor
Science, November 25, 1983; 222(4626): 935 - 937.
[Abstract] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. S. Weisinger, J. R. Blair-West, P. Burns, D. A. Denton, M. J. McKinley, B. Purcell, W. Vale, J. Rivier, and K. Sunagawa
The inhibitory effect of hormones associated with stress on Na appetite of sheep
PNAS, March 14, 2000; 97(6): 2922 - 2927.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society